 biotech monthli monitor preview june
electr power util power/util monthli regulatori
 ga posit bcf vs bbg strh
 explor product number concern remain
internet digit media internet gdpr benefit
expand prime roll-out wfm
lodg cruis line hawaii/volcano exposur
lodg timeshar cruis
switch cancer biolog initi pt
inc buy upgrad
buy pt upgrad buy establish
price target previous believ focu near-
term impact misunderstand around pend scio
acquisit allow entri point attract valuat
three point drive move view posit strateg fit
margin impact scio favor view rpa
backdrop growth attend anywher
privat confer ny confid margin expans
owe inr weak visibl growth higher margin work
get still construct mscc-link benefit buy
better project earn accret leverag
updat investor mscc-link topic fund
detail revenu categor combin compani
guidanc call offer even detail support view
accret estim surpris upsid leverag
surpris downsid support rise stock
ep stay pt stay base
ep pleas click request model
lodg cruis line patrick schole
lodg cruis line patrick schole
 investor day sea reiter growth case address
 jill inc hold lack visibl keep us
sidelin post solid beat momentum build
quarter progress continu may guidanc
came consensu fy outlook provid given
lack visibl encourag recent result
prefer wait sidelin carryov inventori
clear get true read custom reaction
new full-pric assort reiter hold rais pt
upwardli revis estim pt assum forward
est vs histor averag pamela quintiliano
inc hold need
beat consensu expect came guidanc
rang believ in-line guid prove disappoint
encourag recent result long-term
initi await evid stabil trend
becom construct reiter hold pt forward est
magnitud custom acquisit speak continu
momentum anoth remark quarter belt
guidanc momentum continu manag
address next leg growth necessari driver
compar becom increasingli difficult requir similar
result product continu core evidenc
success recent innov plan upcom
launch believ focu along support market
event drive futur result see on-going opportun
growth believ earn bias higher reiter
buy rais pt forward pe vs average pamela
buy rate today analyst day reinforc view
european busi inflect point term
margin improv believ achiev least
ebitda margin euro busi vs
equat ep north rais
adj ep est
account stahlgrub acquisit share trade
lowest multipl margin improv potenti
view highli attract opportun reiter pt
estim pt continu execut continu
exceed high expect ep came vs
consensu believ trend continu
guidanc alreadi consensu
importantli compani look well posit
well note acceler new store open
help drive doubl digit sale growth year highest
level annual basi sinc ipo expect pace
open continu reiter buy rais pt
quarterli estim ad spend pull-forward full year
unchang adjust quarterli cadenc
ep estim follow present investor
confer yesterday chang relat pull forward
ad spend note full-year
ep estim respect
unchang maintain price target
equat ep estim in-lin high-growth
peer maintain buy rate william chappel jr
page
begin play downsid risk current level
continu struggl drive comp healthi margin
gm in-lin consensu assum comp
despit comp gain end-of-quart inventori
elev ship
headwind e-comm expand encourag qtd comp
momentum above-consensu guidanc quarter
benefit lower tax rate shift high volum bt
week late august near-term remain concern
unabl drive gm meaning higher promot
lodg overal revpar y/i week
end per str slightli prior week
result stack revpar vs
prior week independ hotel data
set y/i midscal luxuri
strongest chain scale brand hotel upscal
weakest upper midscal under-perform
overal us hotel industri averag within upper upscal
luxuri class hotel group vs prior week
modestli stronger transient vs prior week
electr power util
electr power util report focus regulatori
trend impact util coverag includ pend rate
case statu merger approv process new rate design
city-bas ps four public two privat yesterday
express optim upcom earn given higher
oil price increas activ though still suggest
number potenti futur issu sharehold return remain
top list public compani though also
import topic though alreadi appear approach
dog day summer would surpris hear number
import announc soon forecast potenti near-
term catalyst neal dingmann
 think today eia inventori report modestli
bullish crude energi stock mmbbl draw crude
inventori help drive mmbbl draw crude primari
product inventori beat consensu estim
mmbbl draw crude primari product draw off-set
mmbbl build product inventori lead
increas total inventori season basi
build total petroleum inventori
averag build week
averag last week ken sill
page
 week bcf inject posit versu
consensu bcf pleas see tabl accompani
graph detail addit pleas see ga storag
preview note yesterday well fitzpatrick neal
kinder morgan inc buy goodby tmx
perhap riddanc increment posit
outlook expect net proce
remov futur leverag kml consolid
there glimps kinder morgan sub leverag
immedi de-lever event close acceler pace
futur de-lever remov regulatori overhang
view would linger throughout construct think
share appear attract incorpor expect
proce leverag outlook modestli reduc
estim reflect sale tmpl current ebitda tristan
investor day takeaway loss momentum attend
investor day nyc came away
increas confid still firmli cycl
expect sequenti earn growth remaind
increment capital-expenditure deploy leas renew
favor rate along strong gain use contain sale
driven limit depot suppli higher steel price
maintain price target equal
adjust book valu pre-tax ep dougla
estim slightli challeng loan growth maintain
buy reduc ep estim
follow manag meet
somewhat higher expens net loan growth
somewhat challeng sentiment heard
bank confer paydown remain high loan
demand hasnt acceler price becom modestli
competit also sba fee affect mix
sba credit make year year
comparison challeng sba loan product remain
switch cancer biolog initi pt
speech drug price biotech pharma indic enjoy
relief ralli investor realiz measur propos
page
administr unlik meaning neg
impact current drug price environ continu
recommend smid cap larg cap counterpart
advis investor focu near-term catalyst
glmd smmt strh
adaptimmun plc adap buy
continu valid year host seri
meet investor adaptimmun manag team
meet center data readout compani
next six month see updat safeti
quarter efficaci data
ny-eso program updat would
buyer ahead data believ adaptimmun spear-t
platform leader cell therapi solid tumor reiter
buy peter lawson
curi inc cri buy posit fda signal
fimepinostat ad back model rais pt today
curi announc fimepinostat receiv fast track statu
fda believ signal fda support
move forward drug await detail
path forward monotherapi vs combo singl arm
vs random base fast track statu start
ad back fimepinostat model initi
likelihood approv adjust pt/model
recent revers share split reiter buy rais
pt post revers split peter lawson
inc buy chat
growth comp cont margin pressur revis
adjust ep estim
adjust ep estim lower
respect price target
remain reflect ebitda estim
ebitda estim histor forward averag
multipl one standard deviat
inc buy upgrad
buy pt upgrad buy establish
price target previous believ focu near-
term impact misunderstand around pend scio
acquisit allow entri point attract valuat
three point drive move view posit strateg fit
margin impact scio favor view rpa
backdrop growth attend anywher
privat confer ny confid margin expans
page
owe inr weak visibl growth higher margin work
brink compani buy acquisit
dunbar posit tobey sommer
get still construct mscc-link benefit buy
better project earn accret leverag
updat investor mscc-link topic fund
detail revenu categor combin compani
guidanc call offer even detail support view
accret estim surpris upsid leverag
surpris downsid support rise stock
ep stay pt stay base
ep pleas click request model
internet digit media highlight week includ
earli report suggest may net beneficiari
gdpr least short-term support thesi
regul like hurt smaller digit ad platform
entrench bigger oper announc
broader roll-out discount prime member whole food
posit prime membership growth view asia
baba made seri announc around logist
believ deepen moat wix enhanc seo
tool deepen partnership youssef squali
page
may ndr head ir new york
may inc ndr ceo cfo kc mid-west
june inc ndr ceo cfo new york boston
june inc ndr cfo svp ir corp manag midatlant
june inc group dinner chairmn ceo cfo chairman carolinas/virginia evp carolinas/virginia
june syntel inc synt ndr vice-president financ head ir texa new
june corp ndr cfo vice-president treasur ir mid-west kc
june ndr presid ceo cfo kc
june dowdupont inc dwdp ndr director ir financ manag ir director ir kc mid-west
page
june inc ndr cfo vice-president ir mid-west canada
june thor industri inc life fit bc bu tour chicago
june nareit meet host suntrust robinson humphrey new york
may michael ciarmoli aerospac defens dalla
june jennif demba michael young bank texa
page
page
issu research report suntrust robinson humphrey inc analyst name report herebi certifi
recommend opinion express accur reflect research analyst person view
subject secur compani discuss herein part research analyst compens directli
indirectli relat specif recommend view express report
